clotting disease

With COVID-19, we should not just be looking at deaths. Deaths may actually be a poor indicator of the damage this virus may do. We should be looking at a continuum, as in: If the proportion of people who contract COVID-19, and who are over 80, die, what happens to those (of any age) who live? Given the ability of this disease (unlike flu) to cause clotting problems all over the body, affecting organs which affect other organs, we should be expecting that a proportion of survivors will have various rates of blood clots and organ damage. What proportion of these will clear, improve, or become chronic and dangerous? How long will how many survivors survive? Check out the following videos by doctors regarding clotting and organ-damage.

[Candobetter Ed: This article was developed from an extract from another, in order to highlight these concepts.]

"More long-term damage caused by COVID-19 than expected | COVID-19 Special" (August 26, 2020)

The above video has many comments of interest, from people who have suffered lingering damage from the virus.

"An NYC Cardiologist Explains the Long Term Effects of COVID-19."

The cardiologist in the above video points out that, even if you are young and fit when you catch COVID-19, you still may not be able to do what you used to do, after you recover. He also says that people should present early for treatment because then treatment can be started to reduce the damage to organs, thus perhaps reducing the severity of chronic conditions that may linger and prevent full recovery. He also says that four years after the 1918 Great Flu epidemic, many survivors still had debilitating symptoms.

"Long-term health effects of COVID-19" (Lung specialist talks about pulmonary fibrosis, which may lead to need for lung transplants.)

Most important to factor in, among all these continuum possibilities, is the incredibly infectious nature of COVID-19, far more than the flu. Cummins does not appear to think much about this.

Perhaps it would be more useful and educative to describe COVID-19 as a clotting disease, than as a respiratory one.